Bicoll
Martinsried
About Bicoll
Bicoll is an expert in the field of plant small molecules backed up by strong medicinal chemistry. Our focus is to deliver breakthrough solutions in pharmaceuticals, cosmetics, nutraceuticals, and agriculture. Bicoll has the proprietary right to the Bicoll Plant Profiles™, which provides the fastest and the most successful method to discover lead compounds from initial screening to animal tests or products. Bicoll offers solutions to hit to lead for drug discovery pipeline from scientifically gathered and carefully processed plant species with outstanding knowledge in high tech natural product chemistry to validated experience in medicinal chemistry. Our global partners and clients allow us to deliver insights and support to discover, innovate and optimize the drug discovery outcomes for patients care. We serve a wide range of clients – from corporates to scientific research groups from all over the world. The robust technology allows us to provide biological screening approaches (whole cell and organism) as well as biochemical HTS set-ups (e.g. protein-protein interaction with FRET-read-out).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $31.4M
- Last round: Grant (Jul 2019)
- Website: bicoll-group.com
- Phone: +498982010630
Industries & Categories
Agriculture, Biotechnology, Nutraceutical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/bicoll-100392 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.